Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07694869RecruitingPhase 1
Study of ammoxetine tablets in people with moderate kidney problems
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
Hefei, AnhuiAges 18–75 - NCT05836948RecruitingPhase 1
Testing SHR-9839 for advanced solid tumors
This Phase 1 trial studies SHR-9839, a new injection medicine, for people with advanced solid tumors that can’t be removed by surgery and have returned or stopped responding to standard care. It mainly aims to find a safe dose and see early signs of whether the treatment can work.
Hangzhou, ZhejiangAges 18–70 - NCT07237230Recruiting
Gamma-delta T cells to prevent leukemia relapse after transplant
This trial tests if a special type of immune cell called gamma-delta T cells can help prevent acute myeloid leukemia from coming back after a stem cell transplant. It is for people with high-risk features who have recently had a transplant.
Wuhan, HubeiAges 18–65 - NCT07604064RecruitingPhase 2
IDH1 Inhibitor Treatment for Relapsed or Refractory Blood Cancer
This trial tests a drug called olutasidenib in Japanese patients with acute myeloid leukemia (a serious blood cancer) that has come back or stopped responding to previous treatment. The drug targets a specific genetic change (IDH1 mutation) that some leukemia cells have, and may help patients whose cancer is difficult to treat.
Tokyo and Other Japanese CitiesAges 18 years+ - NCT05315791Recruiting
Bone-window dental procedure for missing back upper tooth
This study looks at how to place bone support for an upper back tooth replacement when part of the upper jaw bone is limited. If you’re missing one upper back tooth for at least 3 months, they may use a specific “bone window” approach guided by a 3D scan.
Hangzhou, ZhejiangAges 18–80 - NCT07229638RecruitingPhase 1/Phase 2
Study of SHR-9839 with other treatments for solid tumors
This study tests a new drug called SHR-9839 given under the skin, combined with other anti-cancer treatments, for people with solid tumors. The goal is to see if it is safe and effective.
Nanjing, JiangsuAges 18–70 - NCT07696884Recruiting
Vascular graft and endograft infection study
This study looks at how the body responds to infections in artificial blood vessels (vascular grafts or endografts). It may help understand why some people get infections and how to better treat them.
AarhusAges 18 years+ - NCT06746480RecruitingPhase 2
Study of VG161 for advanced bile duct cancer
This trial tests a new medicine called VG161 for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that has stopped responding to or could not be tolerated after at least one prior treatment. It is given by injection into the tumor, and the study wants to see if it can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–75 - NCT07642076RecruitingPhase 4
L-carnitine supplement for critically ill liver disease patients
This study tests whether adding L-carnitine (a naturally occurring compound) to standard care helps people with serious liver disease who are in the intensive care unit. L-carnitine may help the body use energy better and reduce complications from liver failure.
MenoufiaAges 18 years+ - NCT07225803Recruiting
Managing pelvic floor muscle problems that cause constipation
This study tests a treatment for a specific type of constipation caused by pelvic floor muscles not working together properly (dyssynergic defecation). It aims to help people who strain or feel blocked when trying to have a bowel movement.
Rochester, MinnesotaAges 18–80 - NCT06708858RecruitingPhase 2
Studying surufatinib with chemo and immunotherapy for advanced bile duct cancer
This trial tests a combination of a targeted therapy (surufatinib), chemotherapy (gemcitabine and cisplatin), and an immunotherapy (durvalumab or pembrolizumab) for people with advanced bile duct cancer that hasn't been treated with systemic therapy before. The goal is to see if this combination can shrink tumors and improve outcomes.
Beijing, Beijing MunicipalityAges 18–75 - NCT06741527Recruiting
Integrity Implant for rotator cuff repair study
This study is testing a new shoulder implant called the Integrity Implant System to see how well it works for people with rotator cuff tears. It may be a good fit if you need surgery to repair your torn tendon and meet the safety requirements.
Gilbert, ArizonaAges 18 years+ - NCT07559786RecruitingPhase 2
Adebrelimab after chemo-radiation for limited-stage small cell lung cancer
This trial tests whether the drug adebrelimab (a type of immunotherapy) can help prevent your lung cancer from coming back after you finish chemotherapy and radiation. It is for people with limited-stage small cell lung cancer (cancer found only in one lung and nearby lymph nodes) that did not grow during initial treatment.
Zhengzhou, HenanAges 18–75 - NCT06737770Recruiting
Bone-anchored leg implant study
This study tests a bone-anchored implant (directly attached to the thighbone) for people with a single leg amputation above the knee. It aims to see if this implant helps with pain, movement, and skin issues caused by a traditional socket prosthetic.
BolognaAges 18–65 - NCT06238401RecruitingPhase 1
Testing ACR246 for advanced solid tumors
This trial tests a new drug called ACR246 for people with advanced solid tumors that have not responded to standard treatments. The study aims to find the safest dose and see if the drug can shrink tumors.
Beijing, Beijing MunicipalityAges 18–75 - NCT07066449Recruiting
Testing a new ultrasound system for heart surgery
This study is testing a new ultrasound system that takes pictures of your heart from inside your esophagus during surgery. It is for people who are already scheduled for this type of imaging as part of their procedure.
NanjingAges 18 years+ - NCT06732843Recruiting
Comparing two IVF medications for egg and embryo quality
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Abu Dhabi, Abu Dhabi EmirateAges 18–38 - NCT05089149Recruiting
Check how lung ultrasound helps manage heart failure congestion
This study looks at people with long-term worsening heart failure who are coming to the hospital for a planned visit, to see how checking “congestion” (fluid buildup) may guide care. It may help the team understand whether lung ultrasound can better assess who needs treatment changes.
Vandœuvre-lès-NancyAges 18 years+ - NCT07541534RecruitingPhase 1
HLX316 immunotherapy for advanced solid tumors
This trial tests a new experimental drug called HLX316 in people with advanced or metastatic (spread) solid cancers that have not responded to standard treatments. The drug is designed to help your immune system fight cancer cells.
ChongqingAges 18 years+ - NCT07637032Recruiting
Facial cream for rosacea in Chinese women
This study tests a new facial cream to reduce redness and bumps caused by rosacea, a common skin condition. The cream may help calm inflammation and improve the appearance of affected areas on the face.
ShanghaiAges 20–50 - NCT05097898Recruiting
Check fluid buildup in heart failure with normal pumping
This study evaluates how well doctors can assess “fluid congestion” in people with chronic heart failure where the heart’s squeezing is still preserved. It may help improve how patients are monitored during hospital visits.
Vandœuvre-lès-NancyAges 18 years+ - NCT05624879Recruiting
Therapy for grief when caregiving has started
This study tests whether Accelerated Resolution Therapy (ART) can reduce intense “pre-loss” grief in people caring for a loved one who may die within 12 months. You may be able to join if you’re experiencing significant grief before the loss and don’t have certain mental health or substance-use issues.
Phoenix, ArizonaAges 60 years+ - NCT05830825Recruiting
Follow-up study for The Tether to treat scoliosis
This study tracks how well The Tether™ (a growth-friendly spine treatment) works and how people do after surgery in the UK. It is for teens with progressive scoliosis who couldn’t stick with bracing and where their doctor has already decided The Tether is appropriate.
LondonAges birth–30 years - NCT07623564Enrolling by invitation
Breast Surgery Study Using Minimally Invasive Techniques
This study examines how well breast tissue is preserved during cosmetic breast augmentation or reconstruction using new minimally invasive surgical methods. If you're having one of these procedures, this research may help doctors better understand how to maintain healthy breast tissue and improve surgical outcomes.
Coyol, Alajuela ProvinceAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.